Navigation Links
China Kangtai Cactus Biotech Retains Hawk Associates for Investor Relations Services
Date:7/6/2009

HARBIN, China, July 6 /PRNewswire-Asia-FirstCall/ -- China Kangtai Cactus Biotech Inc. (OTC Bulletin Board: CKGT), a vertically integrated grower, developer, manufacturer and marketer of cactus-based consumer products in China, announced today that it has retained the services of Hawk Associates for strategic investor relations. Information about China Kangtai will be available through the Hawk Associates website at: http://www.hawkassociates.com , featuring company updates, investor information and live financial feeds.

China Kangtai CEO Jinjiang Wang said, "We look forward to working with Hawk Associate, which has been providing comprehensive strategic IR services for 14 years in their roles as trusted advisors. We believe Hawk Associates is one of the premier investor relations firms that effectively helps companies successfully communicate their stories to the investment community. The branding and investor relations expertise that Hawk provides will be essential in assisting management in showcasing the true value of our company."

Hawk Associates CEO Frank Hawkins said, "As the dominant producer with 60% market share of China's edible cactus production, China Kangtai is a major beneficiary of growing Chinese demand for health and wellness products. In China, cactus products are traditionally used for treatment for health issues such as diabetes, adiposity, constipation, cholesterol, high blood pressure, low immunity and skin disorders. This is a unique company in an unsaturated industry. With the company's recent acquisition in March, Kangtai is seeking to increase its production capabilities in an effort to enhance its overall growth. We are thrilled to be able to help Kangtai tell its story to the investment community to strengthen its long-term valuation."

About China Kangtai Cactus Biotech, Inc.

China Kangtai Cactus Biotech Inc. is a leading grower, developer, producer and marketer of cactus-derived products, including nutraceuticals, nutritional food and drinks, and animal feed. China Kangtai controls over 387 acres of plants and maintains an active R&D group that holds 18 product patents and is seeking another 12 in a variety of product categories. China Kangtai's high-quality "green" products are sold throughout China in supermarkets, food stores, hotels and restaurants through a growing distribution network that has currently covered 12 provinces and 2 municipalities. For more information, please contact: Chengzhi Wang, General Manager of China Kangtai Cactus Biotech, Inc. Email: chinakangtai@gmail.com

For more investor-related questions, contact Susan Zhou, Hawk Associates, at 305-451-1888. To subscribe to future releases via e-mail alert, visit http://www.hawkassociates.com/about/alert/ .

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.


'/>"/>
SOURCE China Kangtai Cactus Biotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. RainEarth (RNER) Continues to Expand its Marketing Force in China
2. Sinovac Receives Chinas First Influenza A (H1N1) Vaccine Order
3. China-Biotics, Inc. to Join Russell 3000 Index
4. NeoStem Signs Agreement with Shanghai Corporation to Develop A Stem Cell Collection and Treatment Network in Shanghai, Taiwan and Other Targeted China Provinces
5. China Biologic Products Closes the $9.6 Million Private Placement
6. China Biologic Products Enters Into Private Placement Agreements to Raise $9.6 Million
7. Chinas Vice Premier, Li Keqiang, Visits Sinovac to Inspect H1N1 Vaccine Production Preparation
8. Gerresheimer Opens New High-Tech Production Facility for Pharma Glass in China
9. China-Biotics, Inc. to Attend Digestive Disease Week 2009
10. China Sky One Medical, Inc. Obtains Production Approval for Two New Drugs
11. China Sky One Medical, Inc. Signs Agreement with Taiwan Golden Biotechnology Corp. on Development of New Anti-Cancer Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... SEATTLE , Feb. 23, 2017  Seattle,s upscale Capitol ... like a strange place for a head lice treatment salon ... nestled between a Tuscan restaurant and a French bistro on ... it,s perfect. "We aren,t just any old lice clinic, we ... to feel comfortable, and release some of the stigma associated ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... (such as insulin, cortisol, CRP, adiponectin, uric acid, and/or other biomarkers or SNPs ... Insulin Assay from Salimetrics’ SalivaLab , the relationship between insulin and other ...
(Date:2/23/2017)... ... February 22, 2017 , ... Seventy-one members of ... Fellows of the Society this year, the Fellows Committee has announced. The honor ... optics, photonics, and imaging as well as their service to the Society and ...
(Date:2/22/2017)... Scientists propose in Nature blocking ... Gaucher and maybe other lysosomal storage diseases as a ... current therapies. An international research team led ... also included investigators from the University of Lübeck in ... 22. The study was conducted in mouse models of ...
Breaking Biology Technology:
(Date:2/22/2017)... Feb. 22, 2017 With the biometrics ... Research identifies four technologies that innovative and agile ... significant share in the changing competitive landscape: multifactor ... authentication.   "Companies can no longer ... security," says Dimitrios Pavlakis , Industry Analyst ...
(Date:2/13/2017)...  RSA Conference -- RSA, a Dell Technologies business, ... enhance fraud detection and investigation across digital environments ... & Risk Intelligence Suite. The new platform is ... from internal and external sources as well as ... from targeted cybercrime attacks. "Fraudsters are ...
(Date:2/8/2017)... 2017  Aware, Inc. (NASDAQ: AWRE ), a ... results for its quarter and year ended December 31, 2016. ... was $3.9 million compared to $6.9 million in the same ... 2016 was $0.6 million compared to $2.6 million in the ... of 2016 was $0.5 million, or $0.02 per diluted share, ...
Breaking Biology News(10 mins):